BSG/HIS guidelines for use of fecal-microbiota transplant in C. difficile infection
Joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines recommend against the use of fecal microbiota transplant as initial treatment for Clostridium difficile infection. FMT should be used in cases of refractory CDI or in patients with recurrent CDI who have had at least two recurrences. The guidelines are published online August 28, 2018 in the journal Gut.
To continue reading this article
Continue reading your article with a eMediNexus account.